3855 West Chester Pike Suite 230
Newtown Square, PA 19073

Schedule A Free Consultation

IDEAL Breast Implants Have Lower Rates of Wrinkling, Capsular Contracture

With the approval of a third manufacturer of breast implants last year, it seems the FDA is open to expanding the number of options women have when they are considering breast augmentation. In addition to the current manufacturers, we may soon be seeing the IDEAL breast implants as an additional option. Philadelphia breast surgeon Dr. David A. Bottger has been watching the development of the IDEAL breast implant for years and is happy to see that the manufacturers are conducting studies in support of FDA approval. The most recent study reports the 2-year results from an ongoing 10-year trial of the new breast implants.

IDEAL is a saline breast implant that includes a double-lumen (shell). There is a baffle system that connects the two shells and helps prevent the rippling that can plague saline breast implants, and hopefully reduces the rate of capsular contracture and rupture.

At 2 years, the complication rates were as follows:

  • Capsular contracture: 3.8% for primary breast augmentation and 8.2% for revision augmentations
  • Severe to moderate wrinkling: 3.8% and 12.0%, respectively
  • Deflations: 4.8% and 3.3% respectively

Patient satisfaction was high, with 94.3% for primary and 92.3% for revision.

With high satisfaction and low complication rates, it seems that IDEAL breast implants are likely to get approval in upcoming years.

For information about the latest options in breast implants, please contact Dr. David A. Bottger, a board-certified plastic surgeon in Philadelphia.